上海復旦(01385.HK):聯交所確認第15項應用指引不適用於建議分拆上海華嶺赴北交所上市
上海復旦(01385.HK)公佈,有關建議上海華嶺向不特定合格投資者公開發行股份及於北京證券交易所上市,由於考慮到建議公開發行股份及上市可能構成屬於聯交所證券上市規則第15項應用指引項下交易,會向聯交所就根據第15項應用指引提交有關建議公開發行股份及上市之申請。其後,公司於2021年12月10日向聯交所提交申請前的諮詢。
公司指,聯交所已於今年2月9日給予回覆,確認第15項應用指引並不適用於上述建議公開發行股份及上市。據此,公司無需向聯交所繼續進行申請。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.